Daymark Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.63M | Buy |
78,448
+763
| +1% | +$35.3K | 0.14% | 130 |
|
|
2025
Q1 | $4.74M | Sell |
77,685
-279
| -0.4% | -$17K | 0.2% | 100 |
|
|
2024
Q4 | $4.41M | Buy |
77,964
+614
| +0.8% | +$34.7K | 0.19% | 101 |
|
|
2024
Q3 | $4M | Sell |
77,350
-461
| -0.6% | -$23.9K | 0.17% | 110 |
|
|
2024
Q2 | $3.23M | Sell |
77,811
-1,712
| -2% | -$71.1K | 0.15% | 121 |
|
|
2024
Q1 | $4.31M | Buy |
79,523
+5,604
| +8% | +$304K | 0.23% | 91 |
|
|
2023
Q4 | $3.79M | Buy |
73,919
+57
| +0.1% | +$2.93K | 0.23% | 90 |
|
|
2023
Q3 | $4.29M | Buy |
73,862
+19,028
| +35% | +$1.1M | 0.3% | 78 |
|
|
2023
Q2 | $3.51M | Buy |
54,834
+33,627
| +159% | +$2.15M | 0.26% | 87 |
|
|
2023
Q1 | $1.47M | Buy |
21,207
+262
| +1% | +$18.2K | 0.2% | 98 |
|
|
2022
Q4 | $1.51M | Buy |
+20,945
| New | +$1.51M | 0.27% | 75 |
|